申请人:FROST BIOLOGIC, INC.
公开号:US10016398B2
公开(公告)日:2018-07-10
Novel, antimitotic heteroaryl amides and pharmaceutically acceptable salts of Formula I where Ar, R5, R6, R8, R9, R11, X1, and X2 are as defined herein, as compounds for treatment and prevention of cancer and proliferative diseases and disorders.
式 I 的新型抗拮抗杂芳基酰胺和药学上可接受的盐 其中 Ar、R5、R6、R8、R9、R11、X1 和 X2 如本文所定义,可用作治疗和预防癌症及增殖性疾病和紊乱的化合物。